These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37243681)

  • 1. Clinicians' preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force.
    Hidalgo-Mazzei D; Mantingh T; Pérez de Mendiola X; Samalin L; Undurraga J; Strejilevich S; Severus E; Bauer M; González-Pinto A; Nolen WA; Young AH; Vieta E
    Int J Bipolar Disord; 2023 May; 11(1):20. PubMed ID: 37243681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
    Yatham LN; Kennedy SH; Parikh SV; Schaffer A; Bond DJ; Frey BN; Sharma V; Goldstein BI; Rej S; Beaulieu S; Alda M; MacQueen G; Milev RV; Ravindran A; O'Donovan C; McIntosh D; Lam RW; Vazquez G; Kapczinski F; McIntyre RS; Kozicky J; Kanba S; Lafer B; Suppes T; Calabrese JR; Vieta E; Malhi G; Post RM; Berk M
    Bipolar Disord; 2018 Mar; 20(2):97-170. PubMed ID: 29536616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing lithium versus valproate prescription preference in the maintenance treatment of bipolar patients: a report from the Italian Early Career Psychiatrists (SOPSI-GG).
    Buoli M; Gattoni E; Collantoni E; Monteleone AM; Solmi M; Longo L; Ribolsi M; Santambrogio J; Bersani FS; Aguglia A; Serafini G; Signorelli MS; Dell'Osso B; Luciano M; Galderisi S
    Int J Psychiatry Clin Pract; 2021 Mar; 25(1):82-89. PubMed ID: 33380246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of lithium's use: a nationwide survey.
    Pérez de Mendiola X; Hidalgo-Mazzei D; Vieta E; González-Pinto A
    Int J Bipolar Disord; 2021 Mar; 9(1):10. PubMed ID: 33687600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium.
    Nolen WA; Licht RW; Young AH; Malhi GS; Tohen M; Vieta E; Kupka RW; Zarate C; Nielsen RE; Baldessarini RJ; Severus E;
    Bipolar Disord; 2019 Aug; 21(5):394-409. PubMed ID: 31112628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations.
    Yatham LN; Chakrabarty T; Bond DJ; Schaffer A; Beaulieu S; Parikh SV; McIntyre RS; Milev RV; Alda M; Vazquez G; Ravindran AV; Frey BN; Sharma V; Goldstein BI; Rej S; O'Donovan C; Tourjman V; Kozicky JM; Kauer-Sant'Anna M; Malhi G; Suppes T; Vieta E; Kapczinski F; Kanba S; Lam RW; Kennedy SH; Calabrese J; Berk M; Post R
    Bipolar Disord; 2021 Dec; 23(8):767-788. PubMed ID: 34599629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socio-demographic and clinical predictors of outcome to long-term treatment with lithium in bipolar disorders: a systematic review of the contemporary literature and recommendations from the ISBD/IGSLI Task Force on treatment with lithium.
    Grillault Laroche D; Etain B; Severus E; Scott J; Bellivier F;
    Int J Bipolar Disord; 2020 Dec; 8(1):40. PubMed ID: 33330966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety monitoring of treatment in bipolar disorder in a tertiary care setting in Sri Lanka and recommendations for improved monitoring in resource limited settings.
    Mannapperuma U; Galappatthy P; Jayakody RL; Mendis J; de Silva VA; Hanwella R
    BMC Psychiatry; 2019 Jun; 19(1):194. PubMed ID: 31234824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: An ISBD task force report.
    Shulman KI; Almeida OP; Herrmann N; Schaffer A; Strejilevich SA; Paternoster C; Amodeo S; Dols A; Sajatovic M
    Bipolar Disord; 2019 Mar; 21(2):117-123. PubMed ID: 30375703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Lithium in Pediatric Bipolar Disorders and Externalizing Childhood- related Disorders: A Systematic Review of Randomized Controlled Trials.
    Janiri D; Moccia L; Montanari S; Zani V; Prinari C; Monti L; Chieffo D; Mazza M; Simonetti A; Kotzalidis GD; Janiri L
    Curr Neuropharmacol; 2023; 21(6):1329-1342. PubMed ID: 36703581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of lithium-related knowledge and attitudes among patients with bipolar disorder on long-term lithium maintenance treatment.
    Kumar S; Singh S; Mahal P; Vishwakarma A; Deep R
    Indian J Psychiatry; 2020; 62(5):577-581. PubMed ID: 33678841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Concordance of Telemedicine as Compared With Face-to-Face Care in Primary Health Care Clinics in Rural India: Randomized Crossover Trial.
    Verma N; Buch B; Taralekar R; Acharya S
    JMIR Form Res; 2023 Jun; 7():e42775. PubMed ID: 37130015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines.
    Malhi GS; Gessler D; Outhred T
    J Affect Disord; 2017 Aug; 217():266-280. PubMed ID: 28437764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course and need for hospital admission after lithium discontinuation in patients with bipolar disorder type I or II: mirror-image study based on the LiSIE retrospective cohort.
    Öhlund L; Ott M; Bergqvist M; Oja S; Lundqvist R; Sandlund M; Renberg ES; Werneke U
    BJPsych Open; 2019 Nov; 5(6):e101. PubMed ID: 31753046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium for acute mania.
    McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attitudes towards pharmacotherapy in late-life bipolar disorder.
    Rej S; Schuurmans J; Elie D; Stek ML; Shulman K; Dols A
    Int Psychogeriatr; 2016 Jun; 28(6):945-50. PubMed ID: 26778416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.
    Yatham LN; Kennedy SH; Schaffer A; Parikh SV; Beaulieu S; O'Donovan C; MacQueen G; McIntyre RS; Sharma V; Ravindran A; Young LT; Young AH; Alda M; Milev R; Vieta E; Calabrese JR; Berk M; Ha K; Kapczinski F
    Bipolar Disord; 2009 May; 11(3):225-55. PubMed ID: 19419382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiological and behavioral mechanisms of circadian rhythm disruption in bipolar disorder: A critical multi-disciplinary literature review and agenda for future research from the ISBD task force on chronobiology.
    McCarthy MJ; Gottlieb JF; Gonzalez R; McClung CA; Alloy LB; Cain S; Dulcis D; Etain B; Frey BN; Garbazza C; Ketchesin KD; Landgraf D; Lee HJ; Marie-Claire C; Nusslock R; Porcu A; Porter R; Ritter P; Scott J; Smith D; Swartz HA; Murray G
    Bipolar Disord; 2022 May; 24(3):232-263. PubMed ID: 34850507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.